Branle F - Search Results

1

Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis.

Martin B, Paesmans M, Berghmans T, Branle F, Ghisdal L, Mascaux C, Meert AP, Steels E, Vallot F, Verdebout JM, Lafitte JJ, Sculier JP. Martin B, et al. Among authors: branle f. Br J Cancer. 2003 Jul 7;89(1):55-64. doi: 10.1038/sj.bjc.6601095. Br J Cancer. 2003. PMID: 12838300 Free PMC article. Review.

2

Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.

Meert AP, Berghmans T, Branle F, Lemaître F, Mascaux C, Rubesova E, Vermylen P, Paesmans M, Sculier JP. Meert AP, et al. Among authors: branle f. Anticancer Res. 1999 Sep-Oct;19(5C):4379-90. Anticancer Res. 1999. PMID: 10650780 Review.

3

A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis.

Mascaux C, Paesmans M, Berghmans T, Branle F, Lafitte JJ, Lemaitre F, Meert AP, Vermylen P, Sculier JP; European Lung Cancer Working Party (ELCWP). Mascaux C, et al. Among authors: branle f. Lung Cancer. 2000 Oct;30(1):23-36. doi: 10.1016/s0169-5002(00)00127-6. Lung Cancer. 2000. PMID: 11008007 Review.

4

The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature.

Sculier JP, Ghisdal L, Berghmans T, Branle F, Lafitte JJ, Vallot F, Meert AP, Lemaitre F, Steels E, Burniat A, Mascaux C; European Lung Cancer Working Party. Sculier JP, et al. Among authors: branle f. Br J Cancer. 2001 May 4;84(9):1150-5. doi: 10.1054/bjoc.2001.1742. Br J Cancer. 2001. PMID: 11336463 Free PMC article.

5

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis.

Steels E, Paesmans M, Berghmans T, Branle F, Lemaitre F, Mascaux C, Meert AP, Vallot F, Lafitte JJ, Sculier JP. Steels E, et al. Among authors: branle f. Eur Respir J. 2001 Oct;18(4):705-19. doi: 10.1183/09031936.01.00062201. Eur Respir J. 2001. PMID: 11716177 Free article.

6

[The role of chemotherapy in the treatment of non-metastatic, non-small cell bronchial cancers].

Sculier JP, Berghmans T, Paesmans M, Branle F, Lemaitre F, Mascaux C, Meert AP, Steels E, Vallot F, Lafitte JJ. Sculier JP, et al. Among authors: branle f. Rev Med Brux. 2001 Dec;22(6):477-87. Rev Med Brux. 2001. PMID: 11811043 French.

7

Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy.

Branle F, Lefranc F, Camby I, Jeuken J, Geurts-Moespot A, Sprenger S, Sweep F, Kiss R, Salmon I. Branle F, et al. Cancer. 2002 Aug 1;95(3):641-55. doi: 10.1002/cncr.10710. Cancer. 2002. PMID: 12209758 Free article.

8

A multicenter cohort study of dose-dense temozolomide (21 of 28 days) for the treatment of recurrent anaplastic astrocytoma or oligoastrocytoma.

Neyns B, Chaskis C, Joosens E, Menten J, D'Hondt L, Branle F, Sadones J, Michotte A. Neyns B, et al. Among authors: branle f. Cancer Invest. 2008 Apr-May;26(3):269-77. doi: 10.1080/07357900701708393. Cancer Invest. 2008. PMID: 18317968 Clinical Trial.

9

ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges.

Chow LQM, Barlesi F, Bertino EM, van den Bent MJ, Wakelee HA, Wen PY, Chiu CH, Orlov S, Chiari R, Majem M, McKeage M, Yu CJ, Garrido P, Hurtado FK, Arratia PC, Song Y, Branle F, Shi M, Kim DW. Chow LQM, et al. Among authors: branle f. Clin Cancer Res. 2022 Jun 13;28(12):2506-2516. doi: 10.1158/1078-0432.CCR-21-1838. Clin Cancer Res. 2022. PMID: 35091443

10

Temozolomide for the treatment of recurrent supratentorial glioma: results of a compassionate use program in Belgium.

Everaert E, Neyns B, Joosens E, Strauven T, Branle F, Menten J. Everaert E, et al. Among authors: branle f. J Neurooncol. 2004 Oct;70(1):37-48. doi: 10.1023/b:neon.0000040809.97943.c0. J Neurooncol. 2004. PMID: 15527106

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page